black box warning for glp 1 agonists The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw Advances in incretin therapies for

Researchers also study TB-500 , a synthetic peptide based on the active region of the naturally occurring actin-binding protein thymosin beta-4

It works, but its messy

Like with any other medication, doctors can adjust GLP-1s based on their effectiveness, tolerability or side effects, adds Dr

Those considering BPC-157 should understand they are using an experimental compound with unknown long-term effects, sourced from an unregulated market where product quality and purity cannot be guaranteed

DSIPs Effects on CNS Functional State in Children Treated with Antiblastomic Therapy

B12 Supplementation in Patients With Iron Overload For thalassemia patients with iron overload, adding B12 is a big decision